Caelyx

liposomal doxorubicin

Drug timelines are a Plus or Pro feature.

30 regulatory and trial events tracked for Caelyx, covering 2009-07-14 to 2026-04-24. Get the full timeline:

Most recent: EMA Authorised: Caelyx pegylated liposomal (doxorubicin hydrochloride) — Baxter Holding B.V.